Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Zymeworks and LEO Pharma Enter into Bispecific Antibody Licensing and Research Collaboration

pharmafocusasiaDecember 04, 2018

Tag: Zymeworks , LEO Pharma , Bispecific Antibody , defective cellular

PharmaSources Customer Service